Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07217795 · ClinicalTrials.gov registry record · NA

Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building

A NA study of PTSD and Alcohol Use Disorder (AUD), sponsored by University of Rhode Island.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT07217795 is a NA study of PTSD and Alcohol Use Disorder (AUD) that is actively recruiting participants, run by University of Rhode Island. The registered enrollment target is 80 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07217795, a NA study of PTSD and Alcohol Use Disorder (AUD), is actively recruiting participants, sponsored by University of Rhode Island.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

This is a two-part study to develop and test a brief, virtual therapy program for lesbian, gay, bisexual, transgender, and queer (LGBTQ+) people who have experienced trauma and use alcohol. Phase 1: You'll be invited to share your perspective to help make the program relevant, inclusive, and affirming. Phase 2: You may have the opportunity to try the adapted program by receiving free virtual therapy with LGBTQ+-affirming therapists.

Interventions

  • BEHAVIORAL CBT + expressive writing
  • BEHAVIORAL Wait-List Control

Study Locations (1)

Rhode Island

  • University of Rhode Island - Providence

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-11-30
Est. Completion 2028-09
Phase NA

Sponsor

University of Rhode Island

29 total trials

What the Registry Record Tells You About NCT07217795

The ClinicalTrials.gov registry entry for NCT07217795 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (73% lower). The listed sponsor is University of Rhode Island, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with PTSD appearing as the primary indexed condition, and to 2 interventions - of which CBT + expressive writing is the first listed.

NCT07217795 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT07217795 about?

NCT07217795 is a clinical study titled "Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building". This is a two-part study to develop and test a brief, virtual therapy program for lesbian, gay, bisexual, transgender, and queer (LGBTQ+) people who have experienced trauma and use alcohol. Phase 1: You'll be invited to share your perspective to help make the program relevant, inclusive, and affirm...

What is the current status of trial NCT07217795?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-11-30. Estimated completion is 2028-09.

What conditions does trial NCT07217795 study?

This clinical trial studies the following conditions: PTSD, Alcohol Use Disorder (AUD).

What interventions are being tested in trial NCT07217795?

The interventions under investigation include: CBT + expressive writing (BEHAVIORAL), Wait-List Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT07217795?

This trial is sponsored by University of Rhode Island, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07217795 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.